In vivo measurement of human somatic mutations may be a valuable biodo
simeter of exposure to carcinogens and of cancer risk. We have surveye
d translocations at the bcl2 locus in B lymphocytes, and mutations at
hprt in T lymphocytes, in 120 individuals with varying exposure to rad
on and cigarette smoke. bcl2 t(14:18) translocation is the commonest c
hromosomal alteration observed in non-Hodgkins lymphoma (NHL). We obse
rved a significantly larger range of bcl2 translocation Frequency (ran
ge: 0-372 x 10(-6), median: 1.9 x 10(-6)) than of hprt mutation Freque
ncy (range: 0-76.4 x 10(-6) median: 11.1 x 10(-6)),which is likely the
result of clonal proliferation of deathless B cell mutants. We observ
ed that the frequencies of these two distinct lymphocytic mutations ar
e significantly correlated. Although some of the correlated variation
is explained by age, a significant correlation of bcl2 mutagenesis per
sists after age adjustment. Correlated mutagenesis at distinct loci in
distinct cell types could be explained by the existence of a mutator
phenotype or by variation in exposure to environmental mutagens. NHL i
s commoner in men than in women, and our data indicate a trend toward
higher bcl2 mutagenesis in males than females. There is mounting epide
miological evidence For a worldwide increase in NHL, which may have an
environmental basis; molecular epidemiological analysis of bcl2 mutag
enesis in exposed populations might be especially relevant to the iden
tification of putative environmental causes. Given the relative ease o
f the bcl2 assay versus the hpri assay, and the consistency with which
data are reproduced from laboratory to laboratory, it is likely that
the bcl2 assay will be soon added to the array of assays used in human
mutational surveillance. (C) 1997 Wiley-Liss, Inc.